[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-343026-105":59,"doc-detail-343026-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","prevalence-of-diabetes-and-hospitalization-due-to-poor-glycemic-control-in-people-with-bladder-cancer-or-renal-cell-carcinoma-in-sweden","Prevalence of diabetes and hospitalization due to poor glycemic control in people with bladder cancer or renal cell carcinoma in Sweden","","Background: Bladder cancer and renal cell carcinoma are common urogenital cancers and have established links with diabetes. Poor glycemic control can result from diabetes and may be influenced by systemic therapies used for bladder cancer and renal cell carcinoma. Objective: Assess how often diabetes occurs and how frequently hospital-based care is used for malglycemia among people with bladder cancer or renal cell carcinoma. Methods: A Swedish retrospective population register study evaluates co-prevalence, healthcare utilization, systemic corticosteroid use, and diabetes management changes.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/prevalence-of-diabetes-and-hospitalization-due-to-poor-glycemic-control-in-people-with-bladder-cancer-or-renal-cell-carcinoma-in-sweden/343026/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/prevalence-of-diabetes-and-hospitalization-due-to-poor-glycemic-control-in-people-with-bladder-cancer-or-renal-cell-carcinoma-in-sweden/343026.png","ImageObject",300,407,{"name":92,"@type":93},"Liam","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the study objective regarding diabetes in bladder cancer and renal cell carcinoma?","Question",{"text":112,"@type":113},"To investigate the prevalence of diabetes and the use of hospital-based care for malglycemia among people with bladder cancer or renal cell carcinoma in Sweden.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was the study conducted?",{"text":117,"@type":113},"It used Swedish retrospective population-based register data with national health registers to track cancer incidence, hospital-based healthcare use, and outpatient prescription fillings over 15 years.",{"name":119,"@type":110,"acceptedAnswer":120},"What were the key findings about diabetes prevalence and glycemic control?",{"text":121,"@type":113},"Diabetes was registered in 24% of people with bladder cancer and 23% with renal cell carcinoma. An association with poor glycemic control was observed, and earlier insulin-based diabetes management was seen in cancer groups compared with matched type 2 diabetes individuals without cancer.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},343026,1790382076,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":19,"preview_urls":145},8796095461564,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Andersson et al. BMC Urology (2024) 24:148 [https://doi.org/10.1186/s12894-024-01536-2](https://doi.org/10.1186/s12894-024-01536-2)  \nBMC Urology  \n RESEARCH Open Access  \nPrevalence of diabetes and hospitalization due to poor glycemic control in people with bladder cancer or renal cell carcinoma in Sweden  \nEmelie Andersson1*, Gunnar Brådvik1, Fredrik O. L. Nilsson2, Johannes Arpegård2, Angela Strambi2,5, Petter Kollberg3 and Katarina Steen Carlsson1,4  \nAbstract  \nBackground Bladder cancer (BC) and Renal cell carcinoma (RCC) are the most common urogenital cancers among both sexes, with a yearly global incidence of around 500 000 each. Both BC and RCC have been linked to diabetes. Poor glycemic control (malglycemia) is a serious consequence of diabetes and a possible consequence of systemic treatments used in BC and RCC. The objective of this study was to investigate the prevalence of diabetes and use of hospital-based care for malglycemia in people with BC or RCC.  \nMethods This Swedish retrospective population-based register study used national health-data registers for longitudinal data on cancer incidence covering 15 years, use of hospital-based health care, and filled prescriptions of outpatient medications. Study endpoints included co-prevalence of diabetes in individuals with BC/RCC, healthcare resource utilization due to malglycemia, use of systemic corticosteroids, and changes in diabetes management for people with concomitant type 2 diabetes.  \nResults We identified 36,620 and 15,581 individuals diagnosed with BC and RCC, respectively, between 2006 and 2019. The proportion of individuals registered with diabetes was 24% in BC and 23% in RCC. An association between BC/RCC and poor glycemic control was found, although the number of malglycemic events in hospitalbased care were few (65/59 per 1000 individuals with diabetes and BC/RCC respectively with at least one event) . An earlier switch to insulin-based diabetes management was observed in BC/RCC compared to matched individuals with type 2 diabetes but no cancer. The results also indicated an association between steroid treatment and poor glycemic control, and that systemic corticosteroids were more common among people with BC/RCC compared to diabetes controls.  \nConclusion The high prevalence of diabetes and increased use of systemic corticosteroid treatment observed in this large national study highlights the need for specific clinical management, risk-assessment, and monitoring of individuals with BC/RCC and diabetes.  \nKeywords Genitourinary Cancer, Diabetes Mellitus Type 2, Immunomodulating treatment, Nested Case–Control Study, Population Registers, Urinary Bladder Neoplasms, Renal Cell Cancer  \n*Correspondence:  \nEmelie Andersson  \n[emelie.andersson@ihe.se](emelie.andersson@ihe.se)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ()[. The Creative Commons Public Domain Dedication waiver (](http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication wa","cbCaiak1GwVye7OQ","https://ap.wps.com/l/cbCaiak1GwVye7OQ","pdf",1322305,12,"English","# Abstract\n# Introduction\n# Methods\n# Results\n# Conclusion","[{\"question\":\"What was the study objective regarding diabetes in bladder cancer and renal cell carcinoma?\",\"answer\":\"To investigate the prevalence of diabetes and the use of hospital-based care for malglycemia among people with bladder cancer or renal cell carcinoma in Sweden.\"},{\"question\":\"How was the study conducted?\",\"answer\":\"It used Swedish retrospective population-based register data with national health registers to track cancer incidence, hospital-based healthcare use, and outpatient prescription fillings over 15 years.\"},{\"question\":\"What were the key findings about diabetes prevalence and glycemic control?\",\"answer\":\"Diabetes was registered in 24% of people with bladder cancer and 23% with renal cell carcinoma. An association with poor glycemic control was observed, and earlier insulin-based diabetes management was seen in cancer groups compared with matched type 2 diabetes individuals without cancer.\"}]","Prevalence of diabetes and hospitalization due to poor glycemic control in people with bladder cancer or renal cell carcinoma in Sweden | PDF",1790049474,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dd38b5e11fbc4936b643f5dbb7e84c65.webp",983,1305,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2d2e76b6b5e1ec4d31be52222111ab44.webp",982,1304,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9c9356a25bbc8243e440a840f534ab0a.webp",981,1303,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d80ae83761558909ed03e314a2e7a680.webp",980,1301]